In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Alessandro M. Vannucchi discusses the future of experimental therapeutics for the treatment of myeloproliferative neoplasms (MPN).
Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?specialty=Hematology
© 2017 Imedex, LLC.